Latest filing published 07 Jan 2025 for BIOVIE INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Richard J. Berman across 4 companies, led by Cryoport, Inc., Biovie Inc. and Celularity Inc. Over a trading history stretching from 31 December 2015 to 19 December 2024, the count stands at 19 filings.
No open-market purchase appears, only 7 sales worth €584k. Besides market trades, the filings include 10 share grants and 1 option exercise.
The record was last updated on 7 January 2025 with a share grant in Biovie Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations